Award recordCONTRACT

TEVA PHARMACEUTICALS USA, INC.

PIID VA24912P1990· VHA· 626-NASHVILLE· 6505 · DRUGS AND BIOLOGICALS· FY2012· $0 net obligations· UEI NEN9A34LRHJ5· PA

Description

QUETIAPINE (25MG, 100 TABLETS PER BOTTLE, 72 BOTTLES; 50MG, 100 TAB, 72 BTL; 100MG, 100 TAB, 72 BTL; 200MG, 100 TAB, 48 BTL; 300MG, 100 TAB, 48 BTL; 400MG, 100 TAB, 48 BTL)

First action · last action
2012-05-11 · 2012-05-16
Transactions
2
First transaction's obligation
$37,501
Base + all options value (sum of deltas)
$0
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$37,501$0Base award · 2012-05-11 · this action $37,501 · running total $37,501Modification P00001 · 2012-05-16 · this action -$37,501 · running total $0
  • Base2012-05-11+$37,501= $37,501
  • Mod P000012012-05-16-$37,501= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-05-11+$37,501$37,501QUETIAPINE (25MG, 100 TABLETS PER BOTTLE, 72 BOTTLES; 50MG, 100 TAB, 72 BTL; 100MG, 100 TAB, 72 BTL; 200MG, 10…
Mod P00001· FUNDING ONLY ACTION2012-05-16−$37,501$0QUETIAPINE (25MG, 100 TABLETS PER BOTTLE, 72 BOTTLES; 50MG, 100 TAB, 72 BTL; 100MG, 100 TAB, 72 BTL; 200MG, 10…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NEN9A34LRHJ5)

AwardOffice · PSC / listingNet obligationsFY
36F79726D0125NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79723D0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36E79722D0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
VA797E17A0007NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2018
V797D70217NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017
VA797E17C0034NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017

Other recipients under 6505 from 626-NASHVILLE (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24916J2025EISAI INC.626-NASHVILLE$10,442FY2016
VA24916J2023EISAI INC.626-NASHVILLE$9,357FY2016
VA24916J2003LUNDBECK LLC626-NASHVILLE$6,255FY2016
VA24916F1754GRIFOLS THERAPEUTICS LLC626-NASHVILLE$9,974FY2016
VA24916J1738CSL BEHRING L.L.C.626-NASHVILLE$73,561FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24912P1990_3600_-NONE-_-NONE- · retrieved 2026-09-27.